AmorChem II Ventures Inc. is a venture capital fund located in Montreal focused on creating life science companies from promissing projects originating primarily from Quebec-based universities and research centres. Its principal limited partners are Investissement-Québec, FIER Partenaires, Fonds de solidarité FTQ and Merck & Co. AmorChem’s innovative business model involves investing in research-stage projects to enable them to reach a stage where they can attract other financial partners. AmorChem has built a 24-project portfolio across innovative technologies and covering a large breadth of indications.

In addition, in order to enable projects requiring small molecules as tools or drug leads, AmorChem founded NuChem Therapeutics Inc., a medicinal chemistry contract-research company.